- Trials with a EudraCT protocol (137)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
137 result(s) found for: Acetaminophen.
Displaying page 6 of 7.
EudraCT Number: 2006-004834-33 | Sponsor Protocol Number: ROB 803-09-002 | Start Date*: 2007-07-05 | |||||||||||
Sponsor Name:OxyPharma AB | |||||||||||||
Full Title: A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 when Adde... | |||||||||||||
Medical condition: Rheumatiod Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) LV (Completed) GB (Completed) BE (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002149-13 | Sponsor Protocol Number: T705aUS316 | Start Date*: 2013-08-29 | |||||||||||
Sponsor Name:MDVI, LLC | |||||||||||||
Full Title: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza | |||||||||||||
Medical condition: Uncomplicated influenza. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) BG (Completed) NL (Completed) ES (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007859-14 | Sponsor Protocol Number: ARRAY-162-201 | Start Date*: 2008-05-22 | |||||||||||
Sponsor Name:Array BioPharma Inc. | |||||||||||||
Full Title: A 12-WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF ARRY-438162, ADMINISTERED ORALLY DAILY IN PATIENTS WI... | |||||||||||||
Medical condition: Active Rheumatoid Arthritis incompletely responsive to methotrexate | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002772-14 | Sponsor Protocol Number: COX189A2367 | Start Date*: 2005-11-10 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 13-week, multicenter, randomized, double-blind, doubledummy, placebo-controlled, parallel group trial of lumiracoxib (COX189) 100 mg o.d. in patients with primary hip osteoarthritis using celecox... | |||||||||||||
Medical condition: Primary osteoarthritis of the hip | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018564-17 | Sponsor Protocol Number: FAV00A-IIA | Start Date*: 2010-12-30 | |||||||||||
Sponsor Name:Farmak International Holding GmbH | |||||||||||||
Full Title: A Phase II, multicenter, multinational, randomized, double-blinded, placebo-controlled dose-finding study to evaluate the efficacy and safety of carbabenzpyride in the treatment of uncomplicated in... | |||||||||||||
Medical condition: (Uncomplicated) Influenza A | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002598-13 | Sponsor Protocol Number: 42160443PAI3003 | Start Date*: 2015-06-24 | ||||||||||||||||
Sponsor Name:Janssen-Cilag International N.V. | ||||||||||||||||||
Full Title: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteo... | ||||||||||||||||||
Medical condition: Osteoarthritis of the Hip or Knee | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) BE (Completed) CZ (Prematurely Ended) GB (Completed) NL (Completed) PL (Completed) FR (Completed) SK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001197-93 | Sponsor Protocol Number: CG100649-2-01 | Start Date*: 2007-09-21 | ||||||||||||||||
Sponsor Name:CrystalGenomics, Inc. | ||||||||||||||||||
Full Title: Double-blind, placebo controlled Phase II repeat dose study of the safety and efficacy of three parallel loading and maintenance dose regimens of CG100649 versus placebo for the treatment of primar... | ||||||||||||||||||
Medical condition: Primary osteoarthritis (OA) of the knee or hip | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: HU (Completed) DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007510-30 | Sponsor Protocol Number: ARRAY 797-201 | Start Date*: 2009-02-09 | |||||||||||
Sponsor Name:Array BioPharma Inc. | |||||||||||||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF 12 WEEKS OF TREATMENT WITH ... | |||||||||||||
Medical condition: ANKYLOSING SPONDYLITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003224-40 | Sponsor Protocol Number: 42160443PAI3007 | Start Date*: 2015-11-11 | ||||||||||||||||
Sponsor Name:Janssen-Cilag International N.V. | ||||||||||||||||||
Full Title: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms o... | ||||||||||||||||||
Medical condition: Osteoarthritis of the Hip or Knee | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) HU (Completed) SE (Completed) PL (Completed) GB (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003879-37 | Sponsor Protocol Number: 42160443PAI3002 | Start Date*: 2015-07-17 | ||||||||||||||||
Sponsor Name:Janssen-Cilag International NV | ||||||||||||||||||
Full Title: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteo... | ||||||||||||||||||
Medical condition: Osteoarthritis of the Hip or Knee | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000991-27 | Sponsor Protocol Number: 802NP206 | Start Date*: 2018-02-27 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects Wit... | |||||||||||||
Medical condition: Treating Pain Experienced by Subjects With Confirmed Small Fibre Neuropathy That is Idiopathic or Associated With Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Prematurely Ended) GR (Completed) HU (Prematurely Ended) ES (Prematurely Ended) DK (Prematurely Ended) BG (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006665-38 | Sponsor Protocol Number: RBM-001-RA002 | Start Date*: 2022-11-29 | |||||||||||
Sponsor Name:Cyxone AB | |||||||||||||
Full Title: APPRAIS - A 24-week multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy, safety and tolerability of orally administered Rabeximod in patients w... | |||||||||||||
Medical condition: Active, moderate to severe rheumatoid arthritis with inadequate response to methotrexate | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002160-34 | Sponsor Protocol Number: ELP1020 | Start Date*: 2008-10-24 | |||||||||||
Sponsor Name:EleosInc Limited | |||||||||||||
Full Title: Aezea™ (cenersen) in combination with chemotherapy for the treatment of refractory acute myelogenous leukemia subjects ≥ 55 years of age with inadequate response to a single frontline induction cou... | |||||||||||||
Medical condition: Refractory acute myeloid leukemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002517-11 | Sponsor Protocol Number: CD0001 | Start Date*: 2012-02-22 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES GmbH | ||||||||||||||||||
Full Title: A multi-centre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacokinetic of olokizumab administered subcutaneously to subjects with mod... | ||||||||||||||||||
Medical condition: Moderate to severe Crohn’s disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) HU (Prematurely Ended) CZ (Prematurely Ended) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003721-22 | Sponsor Protocol Number: A4091058 | Start Date*: 2016-01-14 | ||||||||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | ||||||||||||||||||
Full Title: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP ... | ||||||||||||||||||
Medical condition: Osteoarthritis of the hip or knee | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) SK (Completed) LT (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-003656-11 | Sponsor Protocol Number: A0081171 | Start Date*: 2007-11-26 | |||||||||||
Sponsor Name:Pfizer, S.A | |||||||||||||
Full Title: ESTUDIO ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO, DE DETERMINACIÓN DE DOSIS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE PREGABALINA EN COMPARACIÓN CON PLACEBO COMO TRATAMIENTO COMPLEMENTARIO DEL DOL... | |||||||||||||
Medical condition: DOLOR POSTOPERATORIO POST SURGICAL PAIN | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: ES (Completed) SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003369-20 | Sponsor Protocol Number: CT-P59_3.2 | Start Date*: 2020-11-13 | |||||||||||
Sponsor Name:Celltrion, Inc | |||||||||||||
Full Title: A Phase 2/3, Randomized, Parallel-group, Placebo-controlled, Double-Blind Study to Evaluate the Efficacy and Safety of CT-P59 in Combination with Standard of Care in Outpatients with Severe Acute R... | |||||||||||||
Medical condition: SARS CoV 2 infection in outpatients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) RO (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003383-47 | Sponsor Protocol Number: TAK-079-1005 | Start Date*: 2020-08-12 | |||||||||||
Sponsor Name:MILLENNIUM PHARMACEUTICALS, INC. | |||||||||||||
Full Title: A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis | |||||||||||||
Medical condition: Generalized Myasthenia Gravis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004999-35 | Sponsor Protocol Number: BKOS-04 | Start Date*: 2014-04-08 | |||||||||||
Sponsor Name:Menarini Ricerche S.p.A. | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, FOUR PARALLEL ARM, DOSE-FINDING STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE INTRA-ARTICULAR INJECTIONS OF FA... | |||||||||||||
Medical condition: Symptomatic osteoarthritis (OA) of the knee. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007723-40 | Sponsor Protocol Number: 0974-034 | Start Date*: 2008-04-25 | ||||||||||||||||
Sponsor Name:Merck Sharp & Dohme (Europe) Inc. | ||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Active- and Placebo-Controlled, Period Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients With St... | ||||||||||||||||||
Medical condition: migraine, coronary artery disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) AT (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
